Brief: Radiopharm Theranostics Confirmed Guidance Of Cash Runway Through To Mid-2026
29/07/2025 12:34
July 29 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: RADIOPHARM THERANOSTICS REPORTS FISCAL YEAR 2025 FINANCIAL RESULTS AND BUSINESS UPDATE RADIOPHARM THERANOSTICS LTD: CONFIRMED GUIDANCE OF CASH RUNWAY THROUGH TO MID-2026 RADIOPHARM THERANOSTICS LTD - FDA GRANTS FAST TRACK DESIGNATION FOR RAD101 Source text: ID:nGNX1RP6GZ Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%